Epilepsia Open is a premier open access journal dedicated to advancing the field of neurology, particularly in the area of epilepsy research and clinical practice. Published by WILEY since 2016, this journal aims to provide a platform for high-quality, peer-reviewed research that fosters collaboration among researchers, clinicians, and educators within the global neurological community. With an impactful presence in the field, it holds a prestigious Q2 ranking in both Neurology and Clinical Neurology categories as of 2023 and has been recognized for its contributions to the understanding of epilepsy through its diverse range of articles, reviews, and clinical studies. Researchers and practitioners can benefit from the journal's open access model, which ensures that valuable findings are readily available to the public, promoting further developments in treatment and care. The journal's significant visibility is reflected in its Scopus rankings, where it ranks in the top half of peer-reviewed journals in both Neurology and Neuroscience categories. For those committed to improving the lives of those affected by epilepsy, Epilepsia Open represents a crucial resource for cutting-edge knowledge and innovative practices.

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

PRACTICAL NEUROLOGY, published by the esteemed BMJ PUBLISHING GROUP, is a prominent journal in the fields of neurology and medicine, significantly impacting clinical practice since its inception in 2001. With an ISSN of 1474-7758 and an e-ISSN of 1474-7766, this UK-based journal reaches a diverse audience of researchers, clinicians, and students who seek to advance their understanding of neurological conditions and patient care strategies. Ranked in the second quartile (Q2) in both the miscellaneous medicine and clinical neurology categories for 2023, and positioned in the 47th percentile among its peers, PRACTICAL NEUROLOGY provides a platform for high-quality research that bridges the gap between laboratory findings and clinical applications. The journal's commitment to disseminating valuable information through peer-reviewed articles ensures that readers are equipped with the latest insights and practical knowledge necessary for improving outcomes in neurology. While access options are not currently open, the journal remains a vital resource for professionals striving to stay at the forefront of neurological research and clinical practice.

Current Journal of Neurology, published by Tehran University of Medical Sciences, is an esteemed Open Access journal dedicated to advancing the field of neurology. Since its inception in 2011, the journal has provided a platform for innovative research and critical discourse in neurology and clinical neurology, with a focus on the latest advancements and methodologies. Although the journal currently holds a Q4 quartile ranking in both neurology and clinical neurology, its goal is to foster the global dissemination of knowledge and ideas relevant to the complexities of neurological disorders. Researchers, professionals, and students exploring this dynamic field will find valuable insights, as the journal aims to bridge the gap between emerging research and clinical application. Based in Tehran, Iran, the Current Journal of Neurology welcomes contributions that enhance understanding and treatment of neurological conditions, thereby promoting evidence-based practices across the globe.

Acta Epileptologica is a prominent open-access journal published by SPRINGERNATURE, dedicated to advancing research in the fields of neurology and clinical neurology. With its ISSN 2096-9384 and E-ISSN 2524-4434, this journal has established itself as a key resource for researchers and practitioners worldwide, particularly since its transition to open access in 2019. Based in the United Kingdom, Acta Epileptologica aims to disseminate high-quality research and foster scholarly collaboration, as evidenced by its consistent Q3 ranking in both neurology and clinical neurology categories as of 2023. Although currently positioned in the lower percentiles on Scopus, the journal plays a critical role in exploring emerging trends and novel therapeutic approaches in epilepsy research, making it an essential platform for academics, healthcare professionals, and students deeply invested in the evolving landscape of neurological disorders.

NEUROPEDIATRICS is a prominent academic journal published by GEORG THIEME VERLAG KG, dedicated to advancing the understanding and treatment of neurological disorders in children. Established in 1980, this journal has consistently provided a platform for innovative research and clinical practice in the fields of pediatrics and neurology, culminating in its recognition across various rankings; it holds a Q2 rating in Pediatrics, Perinatology and Child Health, and Q3 in both Medicine (miscellaneous) and Neurology (clinical) as of 2023. While NEUROPEDIATRICS is not an open access journal, it remains a crucial resource for researchers, clinicians, and students who seek cutting-edge insights and evidence-based practices in the management of pediatric neurological issues. As a result, NEUROPEDIATRICS plays an indispensable role in shaping future research directions and improving health outcomes in this vital field.

Epilepsy & Behavior Reports, a distinguished journal published by ELSEVIER SCIENCE INC, specializes in the latest research and developments in the field of epilepsy and related behavioral conditions. Since its inception in 2019 as a fully Open Access journal, it has carved a niche for itself within the scientific community, providing an essential platform for researchers and clinicians focused on behavioral neuroscience and neurology. The journal's commitment to disseminating high-quality research is reflected in its current rankings within Scopus, placing it within the Q3 category for Behavioral Neuroscience and Clinical Neurology, underscoring its relevance to emerging trends in these fields. Located in the heart of New York, the journal strives to foster collaboration and innovation, making it a vital resource for academics, practitioners, and students eager to advance their understanding of epilepsy and its behavioral implications. The convergence of expertise and research in Epilepsy & Behavior Reports promises to illuminate crucial aspects of neurological health, driving forward the discourse that shapes future treatment and understanding of epilepsy.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY, an esteemed publication under Lippincott Williams & Wilkins, has been at the forefront of disseminating cutting-edge research and clinical advancements since its inception in 1984. With an ISSN of 0736-0258 and an E-ISSN of 1537-1603, this journal serves as a vital resource for professionals and researchers in the fields of medicine, neurology, and physiology, consistently maintaining its prestigious Q2 ranking in various categories as of 2023. It holds a significant position in Scopus rankings, particularly in Clinical Neurology and Physiology, providing insights that are essential for clinicians, neurologists, and scholars alike. Although it does not currently offer open access, it remains a crucial platform for advancing knowledge and practice in clinical neurophysiology. The journal not only aims to foster a deeper understanding of neurophysiological methods and their clinical applications but also encourages innovative research that addresses current challenges in the field. By bridging theory and practice, the JOURNAL OF CLINICAL NEUROPHYSIOLOGY plays an indispensable role in enhancing the quality of patient care and advancing the science of neurology.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.